Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Show more
EDISON, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic...
EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had been developing a...
Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to Treat Parkinson’s Disease Hepion’s Board Unanimously Recommends Shareholders...
KIRYAT ONO, ISRAEL and EDISON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0405 | -18.8372093023 | 0.215 | 0.28 | 0.1559 | 83258418 | 0.2121061 | CS |
4 | -0.3255 | -65.1 | 0.5 | 0.7345 | 0.121 | 26764260 | 0.20750102 | CS |
12 | -0.466 | -72.7556596409 | 0.6405 | 0.74 | 0.121 | 8296085 | 0.20854831 | CS |
26 | -0.6255 | -78.1875 | 0.8 | 0.89 | 0.121 | 3645921 | 0.21194454 | CS |
52 | -1.6455 | -90.4120879121 | 1.82 | 3.4899 | 0.121 | 1895802 | 0.2459591 | CS |
156 | -18.6055 | -99.0708200213 | 18.78 | 26.6 | 0.121 | 804756 | 3.41296899 | CS |
260 | -107.2255 | -99.8375232775 | 107.4 | 123.6 | 0.121 | 1252781 | 28.36679842 | CS |
Symbole | Prix | Vol. |
---|---|---|
TCTMTCTM Kids IT Education Inc | US$ 0,764 (321,87%) | 731,1M |
NVDANVIDIA Corporation | US$ 120,07 (-3,67%) | 388,5M |
RIMEAlgorhythm Holdings Inc | US$ 0,02565 (5,12%) | 341,8M |
CLEUChina Liberal Education Holdings Ltd | US$ 0,1938 (30,77%) | 237,15M |
BHATBlue Hat Interactive Entertainment Technology | US$ 0,0355 (-11,25%) | 236,44M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales